The Nomination Committee of BioGaia has been appointed

AP4 is represented by Jannis Kitsakis, Portfolio Manager.

The Nomination Committee of BioGaia has now been appointed in accordance with the AGM resolutions and following consultation with the company's largest owners.

AP4 is represented by Jannis Kitsakis, Portfolio Manager.

The other members of the committee is:

  •  David Dangoor, Chairman of the Board
  •  Per-Erik Andersson, Annwall & Rothschild Investment AB
  • Sebastian Jahreskog


BioGaia is a health care company that develops, markets and sells probiotic products with documented health benefits. Today BioGaia is a world leader in probiotics thanks to over 20 years experience in the field of probiotics.
The class B share of BioGaia is quoted on the Mid Cap list of the Nordic Exchange Stockholm.